Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Current treatments for alopecia areata in Chinese patients often lead to recovery with recurrence, showing a need for better management.

Alopecia areata moderately affects quality of life, especially in women and those with severe or long-term cases.

JAK inhibitors can help some people with long-standing alopecia areata regrow hair, but many stop treatment due to limited effectiveness.

Serum AMH is a useful biomarker for diagnosing PCOS.

The excimer laser is a promising and safe treatment for frontal fibrosing alopecia.

Intravenous iron therapy effectively treats hair loss due to iron deficiency.

Digital care for hair loss significantly improves men's quality of life.

Ritlecitinib improves hair growth and quality of life in severe alopecia areata with longer use.

Lasers and energy-based devices effectively and safely improve hair growth in androgenetic alopecia, especially when combined with other treatments.

Platelet-rich plasma improves skin flap survival by reducing tissue death.

Air wedge interferometry is a precise, cost-effective way to measure hair thickness.

Polyphenolic compounds may help improve hair growth in non-scarring alopecia.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Fibrosing alopecia starts earlier in Latin American men and often looks like common male pattern baldness.

Alopecia areata causes significant financial strain and dissatisfaction with treatment in Norway and Sweden.

Platelet-rich plasma is effective and safe for hair growth and facial rejuvenation.

Nonculture epidermal suspension is an effective, simple, and safe treatment for stable vitiligo.

Vitamin A levels don't significantly affect alopecia areata.

COVID-19 vaccination may be linked to alopecia areata, especially in young adults.

Hair cortisol levels decrease as children age, stabilizing around age 4.

Alopecia areata may be linked to changes in small blood vessels.

Most patients with alopecia areata did not achieve lasting hair regrowth despite treatment.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Alopecia is more common in younger women, and many patients also have thyroid issues, especially subclinical hypothyroidism.

Androgenetic alopecia in males is linked to significant psychological distress, highlighting the need for both mental and dermatological care.

Virtual healthcare significantly improves quality of life for men with hair loss if they stick to the treatment.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

Intralesional dutasteride improves hair growth in androgenic alopecia with minimal side effects.

FUE technique offers higher satisfaction and broader use for women needing hair transplants.

The gel effectively reduced folliculitis symptoms and was safe to use.